Related Experiment Video
Updated: May 17, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
Muscle protein kinetics in cancer cachexia
Neil Johns1, Nathan A Stephens, Tom Preston
1Department of Clinical Surgery, University of Edinburgh, Edinburgh, Scotland, UK.
Cancer cachexia causes significant skeletal muscle loss, impacting patient outcomes. Understanding muscle protein synthesis and degradation is key to developing new therapies targeting molecular mechanisms.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Skeletal muscle loss is a critical factor in cancer cachexia, correlating with poor prognosis.
- Balancing muscle protein synthesis and degradation is essential for therapeutic development.
Purpose of the Study:
- To review molecular mechanisms regulating protein kinetics in skeletal muscle.
- To identify potential therapeutic targets and measurement methods for muscle loss.
Main Methods:
- Review of recent literature on molecular mechanisms of muscle protein synthesis and degradation.
- Focus on cellular signaling molecules (STAT3, ActRII, TRAF6) and transcriptomic research.
- Discussion of methods for quantifying muscle loss, including radiolabeled amino acids.
Main Results:
- Advances in understanding degradation pathways, particularly autophagy.
- Identification of specific signaling molecules and transcriptomic factors involved in muscle loss.
- Highlighting the need for improved methods to quantify muscle loss for outcome assessment.
Conclusions:
- Appreciation of complex muscle protein synthesis and degradation regulation is crucial for new therapeutics.
- Identifies molecular targets and novel genes for therapeutic intervention.
- Emphasizes the importance of validated methods for measuring muscle kinetics to assess treatment efficacy.
Related Concept Videos
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Muscle Recovery and Fatigue
PI3K/mTOR/AKT Signaling Pathway
